The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Editor’s Choice

Health Canada Licenses Probiotical’s PROBIAL DERM® for Eczema and Atopic Dermatitis Claims
Biotics and Supplements

Health Canada Licenses Probiotical’s PROBIAL DERM® for Eczema and Atopic Dermatitis Claims

OCT 22, 2024
Precision metagenomics: a rapid solution for identifying and characterizing microbial agents of infectious disease.
Editor's Choice

Precision metagenomics: a rapid solution for identifying and characterizing microbial agents of infectious disease.

OCT 17, 2024
Exhaling Clues to the Activity of the Microbiome with Owlstone’s Breath Biopsy Technology – An Interview with Dr. Liz Crone
Editor's Choice

Exhaling Clues to the Activity of the Microbiome with Owlstone’s Breath Biopsy Technology – An Interview with Dr. Liz Crone

OCT 15, 2024
EMIH and MTIG join forces with Microbiome Times on important deal-making event, taking place Brussels 2025
Editor's Choice

EMIH and MTIG join forces with Microbiome Times on important deal-making event, taking place Brussels 2025

SEP 25, 2024
AnonyMine: a platform enabling anonymisation and simulation of microbiome and clinical data
Editor's Choice

AnonyMine: a platform enabling anonymisation and simulation of microbiome and clinical data

SEP 17, 2024
Ferring v Finch: Ripples from the Decision
Editor's Choice

Ferring v Finch: Ripples from the Decision

AUG 14, 2024
Eligo Publishes a Landmark Study in Nature That Unlocks Genome Editing of Bacteria in the Gut
Editor's Choice

Eligo Publishes a Landmark Study in Nature That Unlocks Genome Editing of Bacteria in the Gut

JUL 10, 2024
A New Path Toward Microbiome-Informed Precision Nutrition
Editor's Choice

A New Path Toward Microbiome-Informed Precision Nutrition

JUN 24, 2024
A Synbiotic Step Forward: Dr Lucien Harthoorn talks Synbiotic science, and Clasado’s collaboration with Probi
Biotics and Supplements

A Synbiotic Step Forward: Dr Lucien Harthoorn talks Synbiotic science, and Clasado’s collaboration with Probi

JUN 11, 2024
The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.
Editor's Choice

The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.

MAY 22, 2024
Women’s Health: The Next Microbiome Frontier
Editor's Choice

Women’s Health: The Next Microbiome Frontier

FEB 20, 2024